Readers of histone methylarginine marks

Biochimica et Biophysica Acta - Gene Regulatory Mechanisms

Volumn 1839, Issue 8, 2014, Pages 702-710

  Gayatri, Sitaram ^a   Bedford, Mark T ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Arginine methylation; CARM1; Histone code; PRMT1; Tudor domain

Indexed keywords

ARGININE; HISTONE; LONG UNTRANSLATED RNA; METHYLARGININE; SMALL NUCLEAR RNA; UNCLASSIFIED DRUG;

CONJUGATION; DNA METHYLATION; HISTONE METHYLATION; HISTONE MODIFICATION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW;

ARGININE METHYLATION; CARM1; HISTONE CODE; PRMT1; TUDOR DOMAIN;

ARGININE; CHROMATIN; EPIGENESIS, GENETIC; HISTONES; HUMANS; LYSINE; METHYLATION; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN-ARGININE N-METHYLTRANSFERASES; REPRESSOR PROTEINS; RIBONUCLEOPROTEINS; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION;

EID: 84904048466     PISSN: 18749399     EISSN: 18764320     Source Type: Journal    
DOI: 10.1016/j.bbagrm.2014.02.015     Document Type: Review

References (130)

1. Bedford M.T., Clarke S.G. Protein arginine methylation in mammals: who, what, and why. Mol. Cell 2009, 33:1-13.
2. Bedford M.T., Frankel A., Yaffe M.B., Clarke S., Leder P., Richard S. Arginine methylation inhibits the binding of proline-rich ligands to Src homology 3, but not WW, domains. J. Biol. Chem. 2000, 275:16030-16036.
3. Hughes R.M., Waters M.L. Arginine methylation in a beta-hairpin peptide: implications for Arg-pi interactions, DeltaCp(o), and the cold denatured state. J. Am. Chem. Soc. 2006, 128:12735-12742.
4. Paik W.K., Kim S. Natural Occurrence of Various Methylated Amino Acid Derivatives 1980, John Wiley & Sons, New York.
5. Chang B., Chen Y., Zhao Y., Bruick R.K. JMJD6 is a histone arginine demethylase. Science 2007, 318:444-447.
6. Liu W., Ma Q., Wong K., Li W., Ohgi K., Zhang J., Aggarwal A.K., Rosenfeld M.G. Brd4 and JMJD6-associated anti-pause enhancers in regulation of transcriptional pause release. Cell 2013, 155:1581-1595.
7. Dhar S., Vemulapalli V., Patananan A.N., Huang G.L., Di Lorenzo A., Richard S., Comb M.J., Guo A., Clarke S.G., Bedford M.T. Loss of the major Type I arginine methyltransferase PRMT1 causes substrate scavenging by other PRMTs. Sci. Rep. 2013, 3:1311.
8. Antonysamy S., Bonday Z., Campbell R.M., Doyle B., Druzina Z., Gheyi T., Han B., Jungheim L.N., Qian Y., Rauch C., Russell M., Sauder J.M., Wasserman S.R., Weichert K., Willard F.S., Zhang A., Emtage S. Crystal structure of the human PRMT5:MEP50 complex. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:17960-17965.
9. Ho M.C., Wilczek C., Bonanno J.B., Xing L., Seznec J., Matsui T., Carter L.G., Onikubo T., Kumar P.R., Chan M.K., Brenowitz M., Cheng R.H., Reimer U., Almo S.C., Shechter D. Structure of the arginine methyltransferase PRMT5-MEP50 reveals a mechanism for substrate specificity. PLoS One 2013, 8:e57008.
10. Sun L., Wang M., Lv Z., Yang N., Liu Y., Bao S., Gong W., Xu R.M. Structural insights into protein arginine symmetric dimethylation by PRMT5. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:20538-20543.
11. Troffer-Charlier N., Cura V., Hassenboehler P., Moras D., Cavarelli J. Functional insights from structures of coactivator-associated arginine methyltransferase 1 domains. EMBO J. 2007, 26:4391-4401.
12. Yue W.W., Hassler M., Roe S.M., Thompson-Vale V., Pearl L.H. Insights into histone code syntax from structural and biochemical studies of CARM1 methyltransferase. EMBO J. 2007, 26:4402-4412.
13. Zhang X., Cheng X. Structure of the predominant protein arginine methyltransferase PRMT1 and analysis of its binding to substrate peptides. Structure 2003, 11:509-520.
14. Zhang X., Zhou L., Cheng X. Crystal structure of the conserved core of protein arginine methyltransferase PRMT3. EMBO J. 2000, 19:3509-3519.
15. Gary J.D., Clarke S. RNA and protein interactions modulated by protein arginine methylation. Prog. Nucleic Acid Res. Mol. Biol. 1998, 61:65-131.
16. Matsuoka M. Epsilon-N-methylated lysine and guanidine-N-methylated arginine of proteins. 3. Presence and distribution in nature and mammals. Seikagaku 1972, 44:364-370.
17. Boffa L.C., Karn J., Vidali G., Allfrey V.G. Distribution of NG, NG,-dimethylarginine in nuclear protein fractions. Biochem. Biophys. Res. Commun. 1977, 74:969-976.
18. Bremang M., Cuomo A., Agresta A.M., Stugiewicz M., Spadotto V., Bonaldi T. Mass spectrometry-based identification and characterisation of lysine and arginine methylation in the human proteome. Mol. Biosyst. 2013, 9:2231-2247.
19. Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V., Aguiar M., Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C., Vemulapalli V., Bedford M.T., Comb M.J. Immunoaffinity enrichment and mass spectrometry analysis of protein methylation. Mol. Cell Proteomics. 2014, 13:372-387.
20. Uhlmann T., Geoghegan V.L., Thomas B., Ridlova G., Trudgian D.C., Acuto O. A method for large-scale identification of protein arginine methylation. Mol. Cell. Proteomics 2012, 11:1489-1499.
21. Di Lorenzo A., Bedford M.T. Histone arginine methylation. FEBS Lett. 2011, 585:2024-2031.
22. Casadio F., Lu X., Pollock S.B., Leroy G., Garcia B.A., Muir T.W., Roeder R.G., Allis C.D. H3R42me2a is a histone modification with positive transcriptional effects. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:14894-14899.
23. Anderson D., Koch C.A., Grey L., Ellis C., Moran M.F., Pawson T. Binding of SH2 domains of phospholipase C gamma 1, GAP, and Src to activated growth factor receptors. Science 1990, 250:979-982.
24. Deribe Y.L., Pawson T., Dikic I. Post-translational modifications in signal integration. Nat. Struct. Mol. Biol. 2010, 17:666-672.
25. Ponting C.P. Tudor domains in proteins that interact with RNA. Trends Biochem. Sci. 1997, 22:51-52.
26. Callebaut I., Mornon J.P. The human EBNA-2 coactivator p100: multidomain organization and relationship to the staphylococcal nuclease fold and to the Tudor protein involved in Drosophila melanogaster development. Biochem. J. 1997, 321(Pt 1):125-132.
27. Boswell R.E., Mahowald A.P. Tudor, a gene required for assembly of the germ plasm in Drosophila melanogaster. Cell 1985, 43:97-104.
28. Maurer-Stroh S., Dickens N.J., Hughes-Davies L., Kouzarides T., Eisenhaber F., Ponting C.P. The Tudor domain 'Royal Family': Tudor, plant Agenet, Chromo, PWWP and MBT domains. Trends Biochem. Sci. 2003, 28:69-74.
29. Friesen W.J., Massenet S., Paushkin S., Wyce A., Dreyfuss G. SMN, the product of the spinal muscular atrophy gene, binds preferentially to dimethylarginine-containing protein targets. Mol. Cell 2001, 7:1111-1117.
30. Selenko P., Sprangers R., Stier G., Buhler D., Fischer U., Sattler M. SMN Tudor domain structure and its interaction with the Sm proteins. Nat. Struct. Biol. 2001, 8:27-31.
31. Kolb S.J., Kissel J.T. Spinal muscular atrophy: a timely review. Arch. Neurol. 2011, 68:979-984.
32. Brahms H., Meheus L., de Brabandere V., Fischer U., Luhrmann R. Symmetrical dimethylation of arginine residues in spliceosomal Sm protein B/B' and the Sm-like protein LSm4, and their interaction with the SMN protein. RNA 2001, 7:1531-1542.
33. Bannister A.J., Zegerman P., Partridge J.F., Miska E.A., Thomas J.O., Allshire R.C., Kouzarides T. Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain. Nature 2001, 410:120-124.
34. Lachner M., O'Carroll D., Rea S., Mechtler K., Jenuwein T. Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature 2001, 410:116-120.
35. Botuyan M.V., Lee J., Ward I.M., Kim J.E., Thompson J.R., Chen J., Mer G. Structural basis for the methylation state-specific recognition of histone H4-K20 by 53BP1 and Crb2 in DNA repair. Cell 2006, 127:1361-1373.
36. Huyen Y., Zgheib O., Ditullio R.A., Gorgoulis V.G., Zacharatos P., Petty T.J., Sheston E.A., Mellert H.S., Stavridi E.S., Halazonetis T.D. Methylated lysine 79 of histone H3 targets 53BP1 to DNA double-strand breaks. Nature 2004, 432:406-411.
37. Kim J., Daniel J., Espejo A., Lake A., Krishna M., Xia L., Zhang Y., Bedford M.T. Tudor, MBT and chromo domains gauge the degree of lysine methylation. EMBO Rep. 2006, 7:397-403.
38. Chen C., Jin J., James D.A., Adams-Cioaba M.A., Park J.G., Guo Y., Tenaglia E., Xu C., Gish G., Min J., Pawson T. Mouse Piwi interactome identifies binding mechanism of TDRKH Tudor domain to arginine methylated Miwi. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:20336-20341.
39. Liu H., Wang J.Y., Huang Y., Li Z., Gong W., Lehmann R., Xu R.M. Structural basis for methylarginine-dependent recognition of Aubergine by Tudor. Genes Dev. 2010, 24:1876-1881.
40. Liu K., Chen C., Guo Y., Lam R., Bian C., Xu C., Zhao D.Y., Jin J., MacKenzie F., Pawson T., Min J. Structural basis for recognition of arginine methylated Piwi proteins by the extended Tudor domain. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:18398-18403.
41. Liu K., Guo Y., Liu H., Bian C., Lam R., Liu Y., Mackenzie F., Rojas L.A., Reinberg D., Bedford M.T., Xu R.M., Min J. Crystal structure of TDRD3 and methyl-arginine binding characterization of TDRD3, SMN and SPF30. PLoS One 2012, 7:e30375.
42. Sikorsky T., Hobor F., Krizanova E., Pasulka J., Kubicek K., Stefl R. Recognition of asymmetrically dimethylated arginine by TDRD3. Nucleic Acids Res. 2012, 40:11748-11755.
43. Tripsianes K., Madl T., Machyna M., Fessas D., Englbrecht C., Fischer U., Neugebauer K.M., Sattler M. Structural basis for dimethylarginine recognition by the Tudor domains of human SMN and SPF30 proteins. Nat. Struct. Mol. Biol. 2011, 18:1414-1420.
44. Brzustowicz L.M., Lehner T., Castilla L.H., Penchaszadeh G.K., Wilhelmsen K.C., Daniels R., Davies K.E., Leppert M., Ziter F., Wood D., et al. Genetic mapping of chronic childhood-onset spinal muscular atrophy to chromosome 5q11.2-13.3. Nature 1990, 344:540-541.
45. Cusco I., Barcelo M.J., del Rio E., Baiget M., Tizzano E.F. Detection of novel mutations in the SMN Tudor domain in type I SMA patients. Neurology 2004, 63:146-149.
46. Cheng D., Cote J., Shaaban S., Bedford M.T. The arginine methyltransferase CARM1 regulates the coupling of transcription and mRNA processing. Mol. Cell 2007, 25:71-83.
47. Tadesse H., Deschenes-Furry J., Boisvenue S., Cote J. KH-type splicing regulatory protein interacts with survival motor neuron protein and is misregulated in spinal muscular atrophy. Hum. Mol. Genet. 2008, 17:506-524.
48. Sabra M., Texier P., El Maalouf J., Lomonte P. The Tudor protein survival motor neuron (SMN) is a chromatin-binding protein that interacts with methylated lysine 79 of histone H3. J. Cell Sci. 2013, 126:3664-3677.
49. Talbot K., Miguel-Aliaga I., Mohaghegh P., Ponting C.P., Davies K.E. Characterization of a gene encoding survival motor neuron (SMN)-related protein, a constituent of the spliceosome complex. Hum. Mol. Genet. 1998, 7:2149-2156.
50. Neubauer G., King A., Rappsilber J., Calvio C., Watson M., Ajuh P., Sleeman J., Lamond A., Mann M. Mass spectrometry and EST-database searching allows characterization of the multi-protein spliceosome complex. Nat. Genet. 1998, 20:46-50.
51. Rappsilber J., Ajuh P., Lamond A.I., Mann M. SPF30 is an essential human splicing factor required for assembly of the U4/U5/U6 tri-small nuclear ribonucleoprotein into the spliceosome. J. Biol. Chem. 2001, 276:31142-31150.
52. Meister G., Hannus S., Plottner O., Baars T., Hartmann E., Fakan S., Laggerbauer B., Fischer U. SMNrp is an essential pre-mRNA splicing factor required for the formation of the mature spliceosome. EMBO J. 2001, 20:2304-2314.
53. Cote J., Richard S. Tudor domains bind symmetrical dimethylated arginines. J. Biol. Chem. 2005, 280:28476-28483.
54. Linder B., Plottner O., Kroiss M., Hartmann E., Laggerbauer B., Meister G., Keidel E., Fischer U. TDRD3 is a novel stress granule-associated protein interacting with the Fragile-X syndrome protein FMRP. Hum. Mol. Genet. 2008, 17:3236-3246.
55. Yang Y., Bedford M.T. Protein arginine methyltransferases and cancer. Nat. Rev. Cancer 2013, 13:37-50.
56. Yang Y., Lu Y., Espejo A., Wu J., Xu W., Liang S., Bedford M.T. TDRD3 is an effector molecule for arginine-methylated histone marks. Mol. Cell 2010, 40:1016-1023.
57. Sims R.J., Rojas L.A., Beck D., Bonasio R., Schuller R., Drury W.J., Eick D., Reinberg D. The C-terminal domain of RNA polymerase II is modified by site-specific methylation. Science 2011, 332:99-103.
58. Wang J.C. Cellular roles of DNA topoisomerases: a molecular perspective. Nat. Rev. Mol. Cell Biol. 2002, 3:430-440.
59. Wilson-Sali T., Hsieh T.S. Preferential cleavage of plasmid-based R-loops and D-loops by Drosophila topoisomerase IIIbeta. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:7974-7979.
60. Yang Y., McBride K.M., Hensley S., Lu Y., Chedin F., Bedford M.T. Arginine methylation facilitates the recruitment of TOP3B to chromatin to prevent R loop accumulation. Mol. Cell. 2014, 53:484-497.
61. Xu D., Shen W., Guo R., Xue Y., Peng W., Sima J., Yang J., Sharov A., Srikantan S., Fox D., Qian Y., Martindale J.L., Piao Y., Machamer J., Joshi S.R., Mohanty S., Shaw A.C., Lloyd T.E., Brown G.W., Ko M.S., Gorospe M., Zou S., Wang W. Top3beta is an RNA topoisomerase that works with fragile X syndrome protein to promote synapse formation, Nat. Neurosci. Nat. Neurosci. 2013, 16:1238-1247.
62. Stoll G., Pietilainen O.P., Linder B., Suvisaari J., Brosi C., Hennah W., Leppa V., Torniainen M., Ripatti S., Ala-Mello S., Plottner O., Rehnstrom K., Tuulio-Henriksson A., Varilo T., Tallila J., Kristiansson K., Isohanni M., Kaprio J., Eriksson J.G., Raitakari O.T., Lehtimaki T., Jarvelin M.R., Salomaa V., Hurles M., Stefansson H., Peltonen L., Sullivan P.F., Paunio T., Lonnqvist J., Daly M.J., Fischer U., Freimer N.B., Palotie A. Deletion of TOP3beta, a component of FMRP-containing mRNPs, contributes to neurodevelopmental disorders. Nat. Neurosci. 2013, 16:1228-1237.
63. Laggerbauer B., Ostareck D., Keidel E.M., Ostareck-Lederer A., Fischer U. Evidence that fragile X mental retardation protein is a negative regulator of translation. Hum. Mol. Genet. 2001, 10:329-338.
64. Tong X., Drapkin R., Yalamanchili R., Mosialos G., Kieff E. The Epstein-Barr virus nuclear protein 2 acidic domain forms a complex with a novel cellular coactivator that can interact with TFIIE. Mol. Cell. Biol. 1995, 15:4735-4744.
65. Zheng S., Moehlenbrink J., Lu Y.C., Zalmas L.P., Sagum C.A., Carr S., McGouran J.F., Alexander L., Fedorov O., Munro S., Kessler B., Bedford M.T., Yu Q., La Thangue N.B. Arginine methylation-dependent reader-writer interplay governs growth control by E2F-1. Mol. Cell. 2013, 52:37-51.
66. Yang J., Aittomaki S., Pesu M., Carter K., Saarinen J., Kalkkinen N., Kieff E., Silvennoinen O. Identification of p100 as a coactivator for STAT6 that bridges STAT6 with RNA polymerase II. EMBO J. 2002, 21:4950-4958.
67. Valineva T., Yang J., Palovuori R., Silvennoinen O. The transcriptional co-activator protein p100 recruits histone acetyltransferase activity to STAT6 and mediates interaction between the CREB-binding protein and STAT6. J. Biol. Chem. 2005, 280:14989-14996.
68. Cappellari M., Bielli P., Paronetto M.P., Ciccosanti F., Fimia G.M., Saarikettu J., Silvennoinen O., Sette C. The transcriptional co-activator SND1 is a novel regulator of alternative splicing in prostate cancer cells. Oncogene 2013.
69. Feng Y., Wang J., Asher S., Hoang L., Guardiani C., Ivanov I., Zheng Y.G. Histone H4 acetylation differentially modulates arginine methylation by an in Cis mechanism. J. Biol. Chem. 2011, 286:20323-20334.
70. Li C.L., Yang W.Z., Chen Y.P., Yuan H.S. Structural and functional insights into human Tudor-SN, a key component linking RNA interference and editing. Nucleic Acids Res. 2008, 36:3579-3589.
71. Caudy A.A., Ketting R.F., Hammond S.M., Denli A.M., Bathoorn A.M., Tops B.B., Silva J.M., Myers M.M., Hannon G.J., Plasterk R.H. A micrococcal nuclease homologue in RNAi effector complexes. Nature 2003, 425:411-414.
72. Gao X., Zhao X., Zhu Y., He J., Shao J., Su C., Zhang Y., Zhang W., Saarikettu J., Silvennoinen O., Yao Z., Yang J. Tudor staphylococcal nuclease (Tudor-SN) participates in small ribonucleoprotein (snRNP) assembly via interacting with symmetrically dimethylated Sm proteins. J. Biol. Chem. 2012, 287:18130-18141.
73. Yang J., Valineva T., Hong J., Bu T., Yao Z., Jensen O.N., Frilander M.J., Silvennoinen O. Transcriptional co-activator protein p100 interacts with snRNP proteins and facilitates the assembly of the spliceosome. Nucleic Acids Res. 2007, 35:4485-4494.
74. Holt R., Barnby G., Maestrini E., Bacchelli E., Brocklebank D., Sousa I., Mulder E.J., Kantojarvi K., Jarvela I., Klauck S.M., Poustka F., Bailey A.J., Monaco A.P. Linkage and candidate gene studies of autism spectrum disorders in European populations. Eur. J. Hum. Genet. 2010, 18:1013-1019.
75. Blanco M.A., Aleckovic M., Hua Y., Li T., Wei Y., Xu Z., Cristea I.M., Kang Y. Identification of staphylococcal nuclease domain-containing 1 (SND1) as a Metadherin-interacting protein with metastasis-promoting functions. J. Biol. Chem. 2011, 286:19982-19992.
76. Tsuchiya N., Ochiai M., Nakashima K., Ubagai T., Sugimura T., Nakagama H. SND1, a component of RNA-induced silencing complex, is up-regulated in human colon cancers and implicated in early stage colon carcinogenesis. Cancer Res. 2007, 67:9568-9576.
77. Reuter M., Chuma S., Tanaka T., Franz T., Stark A., Pillai R.S. Loss of the Mili-interacting Tudor domain-containing protein-1 activates transposons and alters the Mili-associated small RNA profile. Nat. Struct. Mol. Biol. 2009, 16:639-646.
78. Vagin V.V., Wohlschlegel J., Qu J., Jonsson Z., Huang X., Chuma S., Girard A., Sachidanandam R., Hannon G.J., Aravin A.A. Proteomic analysis of murine Piwi proteins reveals a role for arginine methylation in specifying interaction with Tudor family members. Genes Dev. 2009, 23:1749-1762.
79. Kacprzyk L.A., Laible M., Andrasiuk T., Brase J.C., Borno S.T., Falth M., Kuner R., Lehrach H., Schweiger M.R., Sultmann H. ERG induces epigenetic activation of Tudor domain-containing protein 1 (TDRD1) in ERG rearrangement-positive prostate cancer. PLoS One 2013, 8:e59976.
80. Boormans J.L., Korsten H., Ziel-van der Made A.J., van Leenders G.J., de Vos C.V., Jenster G., Trapman J. Identification of TDRD1 as a direct target gene of ERG in primary prostate cancer. Int. J. Cancer 2013, 133:335-345.
81. Ross R.J., Weiner M.M., Lin H. PIWI proteins and PIWI-interacting RNAs in the soma. Nature 2014, 505:353-359.
82. Lamb F.S., Barna T.J., Goud C., Marenholz I., Mischke D., Schutte B.C. Complex RNA processing of TDRKH, a novel gene encoding the putative RNA-binding Tudor and KH domains. Gene 2000, 246:209-218.
83. Saxe J.P., Chen M., Zhao H., Lin H. TDRKH is essential for spermatogenesis and participates in primary piRNA biogenesis in the germline. EMBO J. 2013, 32:1869-1885.
84. Kirino Y., Vourekas A., Sayed N., de Lima Alves F., Thomson T., Lasko P., Rappsilber J., Jongens T.A., Mourelatos Z. Arginine methylation of Aubergine mediates Tudor binding and germ plasm localization. RNA 2010, 16:70-78.
85. Vasileva A., Tiedau D., Firooznia A., Muller-Reichert T., Jessberger R. TDRD6 is required for spermiogenesis, chromatoid body architecture, and regulation of miRNA expression. Curr. Biol. 2009, 19:630-639.
86. Guccione E., Bassi C., Casadio F., Martinato F., Cesaroni M., Schuchlautz H., Luscher B., Amati B. Methylation of histone H3R2 by PRMT6 and H3K4 by an MLL complex are mutually exclusive. Nature 2007, 449:933-937.
87. Hyllus D., Stein C., Schnabel K., Schiltz E., Imhof A., Dou Y., Hsieh J., Bauer U.M. PRMT6-mediated methylation of R2 in histone H3 antagonizes H3 K4 trimethylation. Genes Dev. 2007, 21:3369-3380.
88. Iberg A.N., Espejo A., Cheng D., Kim D., Michaud-Levesque J., Richard S., Bedford M.T. Arginine methylation of the histone h3 tail impedes effector binding. J. Biol. Chem. 2008, 283:3006-3010.
89. Michaud-Levesque J., Richard S. Thrombospondin-1 is a transcriptional repression target of PRMT6. J. Biol. Chem. 2009, 284:21338-21346.
90. Qiu Y., Liu L., Zhao C., Han C., Li F., Zhang J., Wang Y., Li G., Mei Y., Wu M., Wu J., Shi Y. Combinatorial readout of unmodified H3R2 and acetylated H3K14 by the tandem PHD finger of MOZ reveals a regulatory mechanism for HOXA9 transcription. Genes Dev. 2012, 26:1376-1391.
91. Rajakumara E., Wang Z., Ma H., Hu L., Chen H., Lin Y., Guo R., Wu F., Li H., Lan F., Shi Y.G., Xu Y., Patel D.J., Shi Y. PHD finger recognition of unmodified histone H3R2 links UHRF1 to regulation of euchromatic gene expression. Mol. Cell 2011, 43:275-284.
92. Fiedler M., Sanchez-Barrena M.J., Nekrasov M., Mieszczanek J., Rybin V., Muller J., Evans P., Bienz M. Decoding of methylated histone H3 tail by the Pygo-BCL9 Wnt signaling complex. Mol. Cell 2008, 30:507-518.
93. Yuan C.C., Matthews A.G., Jin Y., Chen C.F., Chapman B.A., Ohsumi T.K., Glass K.C., Kutateladze T.G., Borowsky M.L., Struhl K., Oettinger M.A. Histone H3R2 symmetric dimethylation and histone H3K4 trimethylation are tightly correlated in eukaryotic genomes. Cell Rep. 2012, 1:83-90.
94. Migliori V., Muller J., Phalke S., Low D., Bezzi M., Mok W.C., Sahu S.K., Gunaratne J., Capasso P., Bassi C., Cecatiello V., De Marco A., Blackstock W., Kuznetsov V., Amati B., Mapelli M., Guccione E. Symmetric dimethylation of H3R2 is a newly identified histone mark that supports euchromatin maintenance. Nat. Struct. Mol. Biol. 2012, 19:136-144.
95. Matthews A.G., Kuo A.J., Ramon-Maiques S., Han S., Champagne K.S., Ivanov D., Gallardo M., Carney D., Cheung P., Ciccone D.N., Walter K.L., Utz P.J., Shi Y., Kutateladze T.G., Yang W., Gozani O., Oettinger M.A. RAG2 PHD finger couples histone H3 lysine 4 trimethylation with V(D)J recombination. Nature. 2007, 450:1106-1110.
96. Ramon-Maiques S., Kuo A.J., Carney D., Matthews A.G., Oettinger M.A., Gozani O., Yang W. The plant homeodomain finger of RAG2 recognizes histone H3 methylated at both lysine-4 and arginine-2. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:18993-18998.
97. Pal S., Vishwanath S.N., Erdjument-Bromage H., Tempst P., Sif S. Human SWI/SNF-associated PRMT5 methylates histone H3 arginine 8 and negatively regulates expression of ST7 and NM23 tumor suppressor genes. Mol. Cell. Biol. 2004, 24:9630-9645.
98. Lacroix M., Messaoudi S.E., Rodier G., Le Cam A., Sardet C., Fabbrizio E. The histone-binding protein COPR5 is required for nuclear functions of the protein arginine methyltransferase PRMT5. EMBO Rep. 2008, 9:452-458.
99. Zhao Q., Rank G., Tan Y.T., Li H., Moritz R.L., Simpson R.J., Cerruti L., Curtis D.J., Patel D.J., Allis C.D., Cunningham J.M., Jane S.M. PRMT5-mediated methylation of histone H4R3 recruits DNMT3A, coupling histone and DNA methylation in gene silencing. Nat. Struct. Mol. Biol. 2009, 16:304-311.
100. Ooi S.K., Qiu C., Bernstein E., Li K., Jia D., Yang Z., Erdjument-Bromage H., Tempst P., Lin S.P., Allis C.D., Cheng X., Bestor T.H. DNMT3L connects unmethylated lysine 4 of histone H3 to de novo methylation of DNA. Nature 2007, 448:714-717.
101. Otani J., Nankumo T., Arita K., Inamoto S., Ariyoshi M., Shirakawa M. Structural basis for recognition of H3K4 methylation status by the DNA methyltransferase 3A ATRX-DNMT3-DNMT3L domain. EMBO Rep. 2009, 10:1235-1241.
102. Girardot M., Hirasawa R., Kacem S., Fritsch L., Pontis J., Kota S.K., Filipponi D., Fabbrizio E., Sardet C., Lohmann F., Kadam S., Ait-Si-Ali S., Feil R. PRMT5-mediated histone H4 arginine-3 symmetrical dimethylation marks chromatin at G+C-rich regions of the mouse genome. Nucleic Acids Res. 2014, 42:235-248.
103. Dhar S.S., Lee S.H., Kan P.Y., Voigt P., Ma L., Shi X., Reinberg D., Lee M.G. Trans-tail regulation of MLL4-catalyzed H3K4 methylation by H4R3 symmetric dimethylation is mediated by a tandem PHD of MLL4. Gene Dev. 2012, 26:2749-2762.
104. Wu J., Xu W. Histone H3R17me2a mark recruits human RNA polymerase-associated factor 1 complex to activate transcription. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:5675-5680.
105. Wu J., Cui N., Wang R., Li J., Wong J. A role for CARM1-mediated histone H3 arginine methylation in protecting histone acetylation by releasing corepressors from chromatin. PLoS One 2012, 7:e34692.
106. Lee Y.H., Bedford M.T., Stallcup M.R. Regulated recruitment of tumor suppressor BRCA1 to the p21 gene by coactivator methylation. Genes Dev. 2011, 25:176-188.
107. Manke I.A., Lowery D.M., Nguyen A., Yaffe M.B. BRCT repeats as phosphopeptide-binding modules involved in protein targeting. Science 2003, 302:636-639.
108. Ulitsky I., Bartel D.P. lincRNAs: genomics, evolution, and mechanisms. Cell 2013, 154:26-46.
109. Bernstein E., Duncan E.M., Masui O., Gil J., Heard E., Allis C.D. Mouse polycomb proteins bind differentially to methylated histone H3 and RNA and are enriched in facultative heterochromatin. Mol. Cell. Biol. 2006, 26:2560-2569.
110. Yang L., Lin C., Liu W., Zhang J., Ohgi K.A., Grinstein J.D., Dorrestein P.C., Rosenfeld M.G. ncRNA- and Pc2 methylation-dependent gene relocation between nuclear structures mediates gene activation programs. Cell 2011, 147:773-788.
111. Nair S.S., Nair B.C., Cortez V., Chakravarty D., Metzger E., Schule R., Brann D.W., Tekmal R.R., Vadlamudi R.K. PELP1 is a reader of histone H3 methylation that facilitates oestrogen receptor-alpha target gene activation by regulating lysine demethylase 1 specificity. EMBO Rep. 2010, 11:438-444.
112. Mann M., Cortez V., Vadlamudi R. PELP1 oncogenic functions involve CARM1 regulation. Carcinogenesis 2013, 34:1468-1475.
113. James L.I., Beaver J.E., Rice N.W., Waters M.L. A synthetic receptor for asymmetric dimethyl arginine. J. Am. Chem. Soc. 2013, 135:6450-6455.
114. Garnier J.M., Sharp P.P., Burns C.J. BET bromodomain inhibitors: a patent review. Expert Opin. Ther. Patient 2014, 24:185-199.
115. James L.I., Barsyte-Lovejoy D., Zhong N., Krichevsky L., Korboukh V.K., Herold J.M., MacNevin C.J., Norris J.L., Sagum C.A., Tempel W., Marcon E., Guo H., Gao C., Huang X.P., Duan S., Emili A., Greenblatt J.F., Kireev D.B., Jin J., Janzen W.P., Brown P.J., Bedford M.T., Arrowsmith C.H., Frye S.V. Discovery of a chemical probe for the L3MBTL3 methyllysine reader domain. Nat. Chem. Biol. 2013, 9:184-191.
116. James L.I., Korboukh V.K., Krichevsky L., Baughman B.M., Herold J.M., Norris J.L., Jin J., Kireev D.B., Janzen W.P., Arrowsmith C.H., Frye S.V. Small-molecule ligands of methyl-lysine binding proteins: optimization of selectivity for L3MBTL3. J. Med. Chem. 2013, 56:7358-7371.
117. Kireev D., Wigle T.J., Norris-Drouin J., Herold J.M., Janzen W.P., Frye S.V. Identification of non-peptide malignant brain tumor (MBT) repeat antagonists by virtual screening of commercially available compounds. J. Med. Chem. 2010, 53:7625-7631.
118. Simon M.D., Chu F., Racki L.R., de la Cruz C.C., Burlingame A.L., Panning B., Narlikar G.J., Shokat K.M. The site-specific installation of methyl-lysine analogs into recombinant histones. Cell 2007, 128:1003-1012.
119. Le D.D., Cortesi A.T., Myers S.A., Burlingame A.L., Fujimori D.G. Site-specific and regiospecific installation of methylarginine analogues into recombinant histones and insights into effector protein binding. J. Am. Chem. Soc. 2013, 135:2879-2882.
120. Wang H., Huang Z.Q., Xia L., Feng Q., Erdjument-Bromage H., Strahl B.D., Briggs S.D., Allis C.D., Wong J., Tempst P., Zhang Y. Methylation of histone H4 at arginine 3 facilitating transcriptional activation by nuclear hormone receptor. Science 2001, 293:853-857.
121. Blythe S.A., Cha S.W., Tadjuidje E., Heasman J., Klein P.S. Beta-catenin primes organizer gene expression by recruiting a histone H3 arginine 8 methyltransferase, Prmt2. Dev Cell 2010, 19:220-231.
122. Karkhanis V., Wang L., Tae S., Hu Y.J., Imbalzano A.N., Sif S. Protein arginine methyltransferase 7 regulates cellular response to DNA damage by methylating promoter histones H2A and H4 of the polymerase delta catalytic subunit gene, POLD1. J. Biol. Chem. 2012, 287:29801-29814.
123. Schurter B.T., Koh S.S., Chen D., Bunick G.J., Harp J.M., Hanson B.L., Henschen-Edman A., Mackay D.R., Stallcup M.R., Aswad D.W. Methylation of histone H3 by coactivator-associated arginine methyltransferase 1. Biochemistry 2001, 40:5747-5756.
124. Tweedie-Cullen R.Y., Brunner A.M., Grossmann J., Mohanna S., Sichau D., Nanni P., Panse C., Mansuy I.M. Identification of combinatorial patterns of post-translational modifications on individual histones in the mouse brain. PLoS One 2012, 7:e36980.
125. Feng Y., Maity R., Whitelegge J.P., Hadjikyriacou A., Zurita-Lopez C., Al-Hadid Q., Thompson P., Richard S., Bedford M.T., Masson J.-Y., Clarke S.G. Mammalian protein arginine methyltransferase 7 (PRMT7) specifically targets histone H2B at R-X-R sites in the N-terminal basic region. J. Biol. Chem. 2013, 288:37010-37025.
126. Tan M., Luo H., Lee S., Jin F., Yang J.S., Montellier E., Buchou T., Cheng Z., Rousseaux S., Rajagopal N., Lu Z., Ye Z., Zhu Q., Wysocka J., Ye Y., Khochbin S., Ren B., Zhao Y. Identification of 67 histone marks and histone lysine crotonylation as a new type of histone modification. Cell 2011, 146:1016-1028.
127. Montellier E., Boussouar F., Rousseaux S., Zhang K., Buchou T., Fenaille F., Shiota H., Debernardi A., Hery P., Curtet S., Jamshidikia M., Barral S., Holota H., Bergon A., Lopez F., Guardiola P., Pernet K., Imbert J., Petosa C., Tan M., Zhao Y., Gerard M., Khochbin S. Chromatin-to-nucleoprotamine transition is controlled by the histone H2B variant TH2B. Gene Dev. 2013, 27:1680-1692.
128. Zhang L., Eugeni E.E., Parthun M.R., Freitas M.A. Identification of novel histone post-translational modifications by peptide mass fingerprinting. Chromosoma 2003, 112:77-86.
129. Ancelin K., Lange U.C., Hajkova P., Schneider R., Bannister A.J., Kouzarides T., Surani M.A. Blimp1 associates with Prmt5 and directs histone arginine methylation in mouse germ cells. Nat. Cell Biol. 2006, 8:623-630.
130. Waldmann T., Izzo A., Kamieniarz K., Richter F., Vogler C., Sarg B., Lindner H., Young N.L., Mittler G., Garcia B.A., Schneider R. Methylation of H2AR29 is a novel repressive PRMT6 target. Epigenetics Chromatin 2011, 4:11.